# Faeth Therapeutics Inc. (FTH)

Source: https://www.quantisnow.com/company/FTH
Generated: 2026-11-08T16:59:23.746Z

- Ticker: FTH
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- SEC CIK: 0001829802
- Website: https://www.senseibio.com

## About

Faeth Therapeutics, Inc. (Nasdaq: FTH) is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The Company's lead program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer. Faeth was co-founded in 2019 by Anand Parikh and Oliver Maddocks, Ph.D., together with scientific founders Lewis Cantley, Ph.D., the discoverer of the PI3K pathway; Siddhartha Mukherjee, M.D., D.Phil.; Karen Vousden, Ph.D.; Scott Lowe, Ph.D.; and Greg Hannon, Ph.D. For more information, please visit www.faeththerapeutics.com and follow the Company on LinkedIn.

## Latest FTH news and filings

- 2026-11-06 21:00 UTC [Faeth to Report PIK-201 Phase 2 Data and Host Virtual Event on November 9, 2026](https://www.quantisnow.com/insight/faeth-to-report-pik-201-phase-2-data-and-host-virtual-6778758)
- 2026-11-05 21:05 UTC [Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://www.quantisnow.com/insight/faeth-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-6776072)
- 2026-11-04 01:33 UTC [SEC Form 4] [President and CEO Parikh Anand Kiran gifted 100,000 shares and received a gift of 100,000 shares, decreasing direct ownership by 12% to 717,699 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-parikh-anand-kiran-gifted-100000-shares-and-6770822)
- 2026-11-03 13:21 UTC [SEC Form S-8] [SEC Form S-8 filed by Faeth Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-faeth-therapeutics-inc-6768693)
- 2026-11-03 13:14 UTC [SEC Form 8-K] [Faeth Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/faeth-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6768648)
- 2026-11-03 13:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Faeth Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-faeth-therapeutics-inc-6768584)
- 2026-11-03 12:30 UTC [Earnings] [Faeth Therapeutics Reports Third Quarter 2026 Financial Results and Operational Updates](https://www.quantisnow.com/insight/faeth-therapeutics-reports-third-quarter-2026-financial-results-and-operational-6768431)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/FTH
- Earnings history: https://www.quantisnow.com/earnings/FTH
- Dividend history: https://www.quantisnow.com/dividends/FTH
- Insider transactions: https://www.quantisnow.com/insiders/FTH
- Options chain: https://www.quantisnow.com/options/FTH
- SEC 8-K filings only: https://www.quantisnow.com/company/FTH/8-k
- RSS and alerts for FTH: https://www.quantisnow.com/docs/rss-feeds.md